Biotech investing isn’t for the faint of heart. The odds that any particular candidate treatment will be a success are low, and commercializing a drug is hard. However, the returns can be amazing when everything goes according to plan. We asked a team of Motley Fool contributors to share the names of some biotech stocks […]

It’s hard to believe, but 2019 is halfway over. Even though the first half of the year has been turbulent at times, the trade war persists, there’s lots of uncertainty surrounding what the Federal Reserve will do next, and tensions with Iran are heating up, the stock market is knocking on the door of new […]

Investors around the world understandably pay close attention to how Warren Buffett, the CEO of Berkshire Hathaway and arguably the world’s greatest living investor, puts his staggering fortune of more than $80 billion to work. Of course, the bulk of that wealth is held in the form of shares of Berkshire Hathaway, where Buffett and […]

No investor can escape occasionally buying a bad stock. It’s painful watching a stock tumble and realizing that it’s unlikely to ever recover. Or even worse, doubling or tripling down before throwing in the towel. In many cases, it’s not all that obvious that a stock should be avoided. In some cases, though, it’s very […]

This week’s spotlight is Facebook (FB), as the company reveals its new cryptocurrency offering today (June 18, as I write this), and on the US Federal Reserve as the Board’s Federal Open Market Committee will conclude its regular policy meeting tomorrow with a much-anticipated position announcement on interest rates. Facebook’s news has been feeding grist […]